Loading...

Cell-Free Platform Will Unlock Broad Personalized Oncology Opportunities

Published
11 Aug 25
n/a
n/a
AnalystHighTarget's Fair Value
n/a
Loading
1Y
-69.1%
7D
5.5%

Author's Valuation

US$583.0% undervalued intrinsic discount

AnalystHighTarget Fair Value